Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the entry. This update does not modify the study data or eligibility criteria.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision label on the page was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor backend or documentation update rather than changes to study data or visible content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew navigation/help items are added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading is updated. The header shows Last verified and Last known status was, with a new Revision: v3.6.0, replacing older labels (Verified, Last known status was:, Intervention / Treatment, Revision: v3.5.5).SummaryDifference1%

- Check32 days agoChange DetectedRevision line updated from v3.5.4 to v3.5.5, indicating a new software release. This update reflects a minor version bump without changes to page content or user-facing features.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, reflecting a minor metadata update rather than a content change.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page’s related topics section now includes “Ovarian cancer” / MedlinePlus Genetics and the displayed site/browser revision has advanced from “v3.5.2” to “v3.5.3”. These are informational/display updates rather than changes to the underlying trial study content.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.